ArticleThoracic cancer2024

Remarkable pathological response to neoadjuvant tepotinib in lung adenocarcinoma with MET exon 14 skipping mutation: A case report.

Rongzhen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.